Product Overview:
Sigrima 420mg Injection is a targeted therapy medicine used in the treatment of breast cancer. It belongs to the group of medicines known as monoclonal antibodies, designed to specifically target and attack cancer cells while minimizing damage to healthy cells.
Administered under the supervision of a qualified healthcare professional, Sigrima Injection is given intravenously (into a vein). The dosage and treatment schedule are determined by your doctor, based on your medical condition, overall health, and response to therapy. Treatment may take several weeks or months to show noticeable results, and it is important to complete the full course as prescribed.
Uses of Sigrima 420mg Injection:
- Treatment of breast cancer
- May be used in combination with other cancer therapies for improved outcomes
Benefits of Sigrima Injection:
- Targets specific cancer cells, helping reduce tumor growth
- Helps improve survival rates in breast cancer patients
- Can be part of a comprehensive cancer treatment plan
Frequently asked questions
What types of pharmaceutical products does Indian Pharmaceuticals offer?
We provide a wide range of pharmaceutical products, including vaccines, hormones, and other essential medications, all manufactured and distributed under strict quality standards.
How does Indian Pharmaceuticals ensure product quality and safety?
We adhere to stringent regulatory compliance and quality assurance protocols, ensuring that all products meet or exceed industry standards for safety and efficacy.
Does Indian Pharmaceuticals offer products for export?
Yes, we have a strong export division and collaborate with international partners to distribute our high-quality pharmaceutical products globally.
What certifications and licenses does Indian Pharmaceuticals hold?
We are certified with GST, 20, 20A, 21, 21A, Retail License, and are a Certified Distributor, ensuring compliance with all necessary regulatory requirements.
Start typing to see products you are looking for.
Chat with us
